Stem is trading at $3.77, down 5.00%, with Susquehanna’s price-target cut potentially weighing on shares.

  • Susquehanna maintained its Neutral rating but lowered its Stem target from $7.50 to $4.50 on October 14.
  • Broader markets were also lower amid hotter-than-expected headline inflation and rate concerns: the S&P 500 fell 0.66% and Nasdaq 0.91%. Those factors may add pressure but do not explain Stem’s larger decline.